title: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
authors.forename: M D
authors.initials: MD
authors.lastname: Cheitlin
authors.forename: P S
authors.initials: PS
authors.lastname: Douglas
authors.forename: W W
authors.initials: WW
authors.lastname: Parmley
mesh_terms: D001022:Aortic Valve Insufficiency / Q000175:diagnosis; D001024:Aortic Valve Stenosis / Q000175:diagnosis; D004608:Eligibility Determination; D015444:Exercise; D006349:Heart Valve Diseases / Q000175:diagnosis* / Q000503:physiopathology / Q000601:surgery; D006350:Heart Valve Prosthesis; D006439:Hemodynamics; D006801:Humans; D008944:Mitral Valve Insufficiency / Q000175:diagnosis; D008946:Mitral Valve Stenosis / Q000175:diagnosis; D005082:Physical Exertion; D013177:Sports; D013178:Sports Medicine; D014262:Tricuspid Valve Insufficiency / Q000175:diagnosis; D014264:Tricuspid Valve Stenosis / Q000175:diagnosis